P-086 - EndoTAG-1 plus gemcitabine versus gemcitabine alone in patients with measurable locally advanced and/or metastatic adenocarcinoma of the pancreas failed on FOLFIRINOX treatment.
Saved in:
| Title: | P-086 - EndoTAG-1 plus gemcitabine versus gemcitabine alone in patients with measurable locally advanced and/or metastatic adenocarcinoma of the pancreas failed on FOLFIRINOX treatment. |
|---|---|
| Authors: | Su, M.1 (AUTHOR), Chen, L.2 (AUTHOR), Hitre, E.3 (AUTHOR), Lee, W.4 (AUTHOR), Bai, L.5 (AUTHOR), Papai, Z.6 (AUTHOR), Kang, S.7 (AUTHOR), Dvorkin, M.8 (AUTHOR), Lee, M.9 (AUTHOR), Ludovic, E.10 (AUTHOR), Choi, H.11 (AUTHOR), Oh, S.12 (AUTHOR), Bodoky, G.13 (AUTHOR), Artru, P.14 (AUTHOR), Hwang, J.15 (AUTHOR), Bazin, I.16 (AUTHOR), Bosc, F.16 (AUTHOR), Bachet, J.17 (AUTHOR), Horváth, Z.16 (AUTHOR), Chang, C.18 (AUTHOR) |
| Source: | Annals of Oncology. 2019 Supplement, Vol. 30, piv23-iv23. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1093/annonc/mdz155.085 |
